Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Prevention and Intervention Approaches for Fetal Alcohol…

U.S. National Institutes of Health·United States of America

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Closes 11/17/2026$500k – $2MGrants Notice
Get bids like this by emailBid source

Description

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD, and interventions for FASD. The funding mechanism is the Exploratory/Developmental Phased Award (R61/R33) with an optional clinical trial. Key aspects of this opportunity include: * Prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD * Interventions for FASD * The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility * The R33 phase will support research testing the hypotheses * Clinical trials are optional but will be given highest priority * Eligible applicants include various organizations, such as state governments, nonprofits, and institutions of higher education.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
11/22/2023
Closes
11/17/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-158

Budget estimate

$500,000 – $2,000,000

The budget amount for this grant is not specified, but based on the nature of the project, which involves research and development of prevention and intervention strategies, the estimated budget could be in the range of $500,000 to $2 million. This estimate is rough and may vary depending on the scope and complexity of the proposed project. Factors that may influence the budget amount include the number of applicants, the quality of the proposals, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 97%

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 11/22/2023

U.S. National Institutes of Health·United States of America

91% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

86% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

86% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. National Institutes of Health·United States of America

85% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. National Institutes of Health·United States of America

84% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

83% match

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 2/8/2021

U.S. National Institutes of Health·United States of America

83% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

83% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

82% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

82% match

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

Closes 11/15/2027Opened 12/16/2024

U.S. Food and Drug Administration·United States of America

82% match

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Closes 5/16/2028Opened 7/11/2025

U.S. National Institutes of Health·United States of America

81% match

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Closes 6/15/2028Opened 9/25/2025

U.S. National Institutes of Health·United States of America

81% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

81% match

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 9/11/2023

U.S. National Institutes of Health·United States of America

81% match

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 5/10/2022

U.S. Centers for Disease Control - NCIPC·United States of America

81% match

Preventing Violence Affecting Young Lives (PREVAYL 2.0)

Closes 6/1/2027Opened 8/17/2026

U.S. National Institutes of Health·United States of America

80% match

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Closes 6/2/2027Opened 6/17/2024

U.S. National Institutes of Health·United States of America

80% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

80% match

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Closes 11/5/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

80% match

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

Closes 5/7/2029Opened 9/15/2025

U.S. Centers for Disease Control - NCBDDD·United States of America

80% match

Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge

Closes 5/25/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

80% match

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

Closes 3/16/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

80% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

80% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024